Effector Therapeutics Doses First Patient In Second Cohort Of Phase 1B Clinical Trial Of Zotatifin For The Treatment Of COVID-19

Press/Media

Period	14 Sep 2022

Media coverage

Title	Effector Therapeutics Doses First Patient In Second Cohort Of Phase 1B Clinical Trial Of Zotatifin For The Treatment Of COVID-19
Media name/outlet	MENAFN -Press Releases (English)
Country/Territory	Jordan
Date	14/09/22
URL	metabase.moreover.com/noarticleurl?type=psh&lni=66R3-J731-DY6B-23F9-00000-00
Persons	Nevan Krogan